Viewing nowLosartan Potassium Tablet 100 mg
Losartan Potassium 100mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 201109188 · Approved 2011.10.26 · Insurance code 648506680
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus accompanied by hypertension
This medication is used to effectively lower blood pressure in patients with hypertension. It also helps to prevent or treat the progression of nephropathy that can occur in patients with type 2 diabetes and hypertension. Therefore, it plays an important role not only in blood pressure control but also in managing diabetic kidney complications. This drug stabilizes blood pressure, reduces the risk of cardiovascular disease, and protects kidney function.
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after the start of treatment. If the therapeutic effect is insufficient, the same dose may be administered orally in 2 divided doses, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). Elderly patients: No adjustment of the initial dose is necessary in elderly patients up to 75 years of age. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Patients with renal impairment - Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Patients with renal impairment - Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. Patients with reduced effective intravascular volume: An initial dose of 25 mg of this drug once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic treatment) (see the section on precautions for use). Patients with hepatic impairment: A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Pediatric and adolescent patients aged 6 years and older who weigh 20 kg or more and less than 50 kg and can swallow tablets: The recommended dose is 25 mg of this medicine once daily, and the dose may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Pediatric and adolescent patients aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, and the dose may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate of less than 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious damage to the fetus if taken during pregnancy, especially during the second and third trimesters; therefore, it should be discontinued immediately if pregnancy is confirmed. This drug should not be administered to patients with certain conditions, such as severe liver impairment or hereditary angioedema. Elderly patients, those with impaired kidney function, and patients with hyperkalemia should exercise caution when using this medication and should take it under the careful guidance of a physician. During treatment, symptoms such as dizziness or hypotension may occur, so caution is advised, especially when driving or operating machinery. Occasionally, this medication may cause side effects such as angioedema, liver function abnormalities, muscle pain, and hyperkalemia. If any abnormal symptoms occur, consult a healthcare professional immediately. There may be interactions with other medications, so if you are taking other medicines, be sure to inform your physician or pharmacist. Taking this drug with potassium-sparing diuretics or potassium supplements may cause dangerously elevated potassium levels, so caution is required. Women who are pregnant or breastfeeding should avoid taking this medication; if it must be taken, consult a doctor for appropriate measures. For children or patients with severely impaired kidney function, the safety and efficacy of this drug have not been sufficiently established, so it is best not to use it. In the case of overdose, symptoms such as hypotension and bradycardia may occur, so care should be taken to avoid exceeding the recommended dose, and if any abnormal symptoms appear, seek medical attention immediately. This medication should be kept out of the reach of children and should not be transferred to other containers, as this may jeopardize its quality.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container to protect it from air and moisture. It is also important to maintain room temperature between 1 and 30 degrees Celsius while storing the medicine. This will help maintain the drug's effectiveness for a longer time.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 100mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.